novo nordisk glp-1 drug Nordisk's Wegovy pill launch draws new wave of patients to GLP-1s Novo Nordisk, Hims & Hers

GLP-1 drugs are already changing how we treat obesity-related comorbidities

One innovative therapy we offer involves GLP-1 receptor agonists, such as Ozempic, to effectively support patients in managing type 2 diabetes and achieving their weight-loss goals

What the Study Shows The study published in Nature Medicine included 376 people in the United States who had previously taken weight management injectables

Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, Musi N, DeFronzo RA, and Cersosimo E

However, several important considerations emerge when combining these interventions

For every point drop in hemoglobin A1C (HbA 1C ) patients can reduce their risk for microvascular complications by 40%